Repligen (RGEN) EV to EBITDA (2009 - 2026)
Repligen's EV to EBITDA came in at 42.86 for Q2 2026, down 54.5% from 94.22 a year earlier but up 18.0% from the prior quarter.
Powered by 
Analysis
Repligen (RGEN) EV to EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Repligen reported EV to EBITDA of 28.54, down 53.0% year-over-year; for FY2025, it was 56.20, down 61.5% from FY2024.
- Going back by year, EV to EBITDA was 145.90 in FY2024 (+86.7%), 78.14 in FY2023 (+146.9%), 31.65 in FY2022 (-51.1%) and 64.67 in FY2021 (-28.7%).
- The five-year range for quarterly EV to EBITDA is 31.65 (Q4 2022) to 145.90 (Q4 2024).
- Year-over-year, EV to EBITDA has declined for four consecutive quarters, with growth averaging 5.0% over the last eight quarters.
- The fastest year-over-year change in EV to EBITDA over five years came in Q4 2023 (growth of 146.9%), and the weakest in Q1 2026 (a decline of 69.0%).
- Business Quant data shows RGEN's EV to EBITDA at 36.33 (Q1 2026), 56.20 (Q4 2025) and 71.86 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.44 Bn | 236.08 Bn | 5.13 Bn |
| 2 | Abbott Laboratories | 187.98 Bn | 162.45 Bn | 7.39 Bn |
| 3 | Danaher | 163.91 Bn | 143.58 Bn | 3.84 Bn |
| 4 | Intuitive Surgical | 153.75 Bn | 134.17 Bn | 2.08 Bn |
| 5 | Medtronic | 131.67 Bn | 97.80 Bn | 6.34 Bn |
| 6 | Stryker | 117.84 Bn | 104.03 Bn | 4.25 Bn |
| 7 | Boston Scientific | 64.27 Bn | 59.95 Bn | 3.43 Bn |
| 8 | Edwards Lifesciences | 61.69 Bn | 45.00 Bn | 1.35 Bn |
| 9 | Medline | 51.94 Bn | 49.07 Bn | 1.93 Bn |
| 10 | Repligen | 9.51 Bn | 6.29 Bn | 110.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 91.50 |
| Jun 30, 2026 | 43.90 |
| Mar 31, 2026 | 37.20 |
| Dec 31, 2025 | 57.65 |
| Sep 30, 2025 | 74.86 |
| Jun 30, 2025 | 94.22 |
| Mar 31, 2025 | 117.29 |
| Dec 31, 2024 | 145.90 |
| Sep 30, 2024 | 81.64 |
| Jun 30, 2024 | 59.97 |
| Mar 31, 2024 | 83.62 |
| Dec 31, 2023 | 78.14 |
| Sep 30, 2023 | 53.43 |
| Jun 30, 2023 | 37.35 |
| Mar 31, 2023 | 37.26 |
| Dec 31, 2022 | 31.65 |
| Sep 30, 2022 | 36.98 |
| Jun 30, 2022 | 32.60 |
| Mar 31, 2022 | 40.60 |
| Dec 31, 2021 | 64.04 |
API Access
Repligen EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=RGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "RGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=RGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();